24 results
424B5
RPHM
Reneo Pharmaceuticals Inc
4 May 23
Prospectus supplement for primary offering
5:15pm
to specified conditions, to purchase a number of additional shares proportionate to that underwriter’s initial purchase commitment as indicated
424B5
RPHM
Reneo Pharmaceuticals Inc
3 May 23
Prospectus supplement for primary offering
4:20pm
conditions, to purchase a number of additional shares proportionate to that underwriter’s initial purchase commitment as indicated in the table above
DEF 14A
RPHM
Reneo Pharmaceuticals Inc
22 Apr 22
Definitive proxy
4:05pm
excellence in his or her field, having the ability to exercise sound business judgment and having the commitment to rigorously represent the long-term
10-K
EX-10.14
acavdwahcyqpmcd9
23 Mar 22
Annual report
4:38pm
10-K
mrz8j e1s
23 Mar 22
Annual report
4:38pm
10-K
EX-10.12
6m1l n95yb2opf5j2
23 Mar 22
Annual report
4:38pm
10-Q
re2mw2
20 May 21
Quarterly report
7:00am
8-K
EX-3.2
abjqmgl7xs7f5u0fhgsi
13 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:36pm
424B4
twq01xauaaajq yk1
9 Apr 21
Prospectus supplement with pricing info
4:41pm
S-8
EX-99.3
rzoud1lrni1iuxd yw
8 Apr 21
Registration of securities for employees
9:44pm
S-1/A
EX-10.1
vx1f1th2fbujipj066q9
5 Apr 21
IPO registration (amended)
9:12am
S-1/A
6d401gd2m2j hdct4pp2
5 Apr 21
IPO registration (amended)
9:12am
S-1/A
EX-3.1
ukbxfquwty 4upts
5 Apr 21
IPO registration (amended)
9:12am
S-1/A
EX-10.5
id57veh3rg8m9w w7
5 Apr 21
IPO registration (amended)
9:12am
S-1/A
EX-10.3
dvpf2ns10kn9yf
5 Apr 21
IPO registration (amended)
9:12am
S-1
EX-3.4
gm4fpb
19 Mar 21
IPO registration
5:27pm